Triazolam

Generic name: Pronounced as (trye ay' zoe lam)
Brand names
  • Halcion®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 05/15/2021

Triazolam may increase the risk of serious or life-threatening breathing problems, sedation, or coma if used along with certain medications. Tell your doctor if you are taking or plan to take certain opiate medications for cough such as codeine (in Triacin-C, in Tuzistra XR) or hydrocodone (in Anexsia, in Norco, in Zyfrel) or for pain such as codeine (in Fiorinal), fentanyl (Actiq, Duragesic, Subsys, others), hydromorphone (Dilaudid, Exalgo), meperidine (Demerol), methadone (Dolophine, Methadose), morphine (Astramorph, Duramorph PF, Kadian), oxycodone (in Oxycet, in Percocet, in Roxicet, others), and tramadol (Conzip, Ultram, in Ultracet). Your doctor may need to change the dosages of your medications and will monitor you carefully. If you take triazolam with any of these medications and you develop any of the following symptoms, call your doctor immediately or seek emergency medical care immediately: unusual dizziness, lightheadedness, extreme sleepiness, slowed or difficult breathing, or unresponsiveness. Be sure that your caregiver or family members know which symptoms may be serious so they can call the doctor or emergency medical care if you are unable to seek treatment on your own.

Triazolam may be habit forming. Do not take a larger dose, take it more often, or for a longer time than your doctor tells you to. Tell your doctor if you have ever drunk large amounts of alcohol, if you use or have ever used street drugs, or have overused prescription medications. Do not drink alcohol or use street drugs during your treatment. Drinking alcohol or using street drugs during your treatment with triazolam also increases the risk that you will experience these serious, life-threatening side effects. Also tell your doctor if you have or have ever had depression or another mental illness.

Triazolam may cause a physical dependence (a condition in which unpleasant physical symptoms occur if a medication is suddenly stopped or taken in smaller doses), especially if you take it for several days to several weeks. Do not stop taking this medication or take fewer doses without talking to your doctor. Stopping triazolam suddenly can worsen your condition and cause withdrawal symptoms that may last for several weeks to more than 12 months. Your doctor probably will decrease your triazolam dose gradually. Call your doctor or get emergency medical treatment if you experience any of the following symptoms: unusual movements; ringing in your ears; anxiety; memory problems; difficulty concentrating; sleep problems; seizures; shaking; muscle twitching; changes in mental health; depression; burning or prickling feeling in hands, arms, legs or feet; seeing or hearing things that others do not see or hear; thoughts of harming or killing yourself or others; overexcitement; or losing touch with reality.

Triazolam is used on a short-term basis to treat insomnia (difficulty falling asleep or staying asleep). Triazolam is in a class of medications called benzodiazepines. It works by slowing activity in the brain to allow sleep.

Triazolam comes as a tablet to take by mouth. It is usually taken as needed at bedtime but not with or shortly after a meal. Triazolam may not work well if it is taken with food. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take triazolam exactly as directed.

You will probably become very sleepy soon after you take triazolam and will remain sleepy for some time after you take the medication. Plan to go to bed right after you take triazolam and to stay in bed for 7 to 8 hours. Do not take triazolam if you will be unable to remain asleep for 7 to 8 hours after taking the medication. If you get up too soon after taking triazolam, you may experience memory problems.

Your sleep problems should improve within 7 to 10 days after you start taking triazolam. Call your doctor if your sleep problems do not improve during this time, if they get worse at any time during your treatment, or if you notice any changes in your thoughts or behavior.

Triazolam should normally be taken for short periods of time (usually 7 to 10 days). You should not take triazolam for more than 2 to 3 weeks without talking to your doctor. If you take triazolam for 7 to 10 days or longer, triazolam may not help you sleep as well as it did when you first began to take the medication, and you may wake up more easily during the last third of the night. You may also start to feel anxious or nervous during the day, and you may develop dependence ('addiction'; a need to continue taking the medication) on triazolam. Talk to your doctor about the risks of taking triazolam for 2 weeks or longer.

You may have more difficulty falling asleep or staying asleep on the first few nights after you stop taking triazolam than you did before you started taking the medication. This is normal and usually gets better without treatment after one or two nights.

Your doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with triazolam and each time you refill your prescription. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website (http://www.fda.gov/Drugs) or the manufacturer's website to obtain the Medication Guide.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking triazolam,

  • tell your doctor and pharmacist if you are allergic to triazolam; other benzodiazepines; any other medications; or any of the ingredients in triazolam tablets. Ask your pharmacist for a list of the ingredients.

  • tell your doctor if you are taking any of the following medications: antifungal medications including itraconazole (Onmel, Sporanox) and ketoconazole (Nizoral); certain medications for human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS) including indinavir (Crixivan), lopinavir (in Kaletra), nelfinavir (Viracept), ritonavir (Norvir, in Kaletra), and saquinavir (Invirase); and nefazodone. Your doctor will probably tell you not to take triazolam.

  • tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: amiodarone (Nexterone, Pacerone); certain antibiotics such as clarithromycin (Biaxin, in Prevpac), erythromycin (Erythrocin, E-mycin), telithromycin (Ketek), and troleandomycin (TAO) (not available in the US); antidepressants; certain antifungal medications; antihistamines; certain calcium channel blockers such as diltiazem (Cardizem, Dilacor, Tiazac, others), nicardipine (Cardene), nifedipine (Adalat, Afeditab, Procardia), and verapamil (Calan, Verelan); cyclosporine (Gengraf, Neoral, Sandimmune); ergotamine (Cafergot, Ergomar, Migranal, others); certain histamine-2 receptor blockers (H2 blockers) such as cimetidine (Tagamet) and ranitidine (Zantac); hormonal contraceptives (birth control pills, patches, rings, implants, or injections); isoniazid (Laniazid, in Rifamate, in Rifater); medications for anxiety, colds or allergies, mental illness, or seizures; muscle relaxants; sedatives; certain selective serotonin reuptake inhibitors (SSRIs) such as fluvoxamine (Luvox), paroxetine (Brisdelle, Paxil, Pexeva), and sertraline (Zoloft); other sleeping pills; and tranquilizers. Your doctor may need to change the doses of your medications or monitor you carefully for side effects. Many other medications may also interact with triazolam, so be sure to tell your doctor about all the medications you are taking, even those that do not appear on this list.

  • tell your doctor if you have ever thought about killing yourself or tried to do so, and if you have or have ever had any condition that affects your breathing, sleep apnea (condition in which a person briefly stops breathing many times during the night), seizures, or kidney or liver disease.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. If you become pregnant while taking triazolam, call your doctor immediately. Triazolam may harm the fetus.

  • talk to your doctor about the safe use of triazolam if you are 65 years of age or older. Older adults should usually take lower doses of triazolam because higher doses may not be more effective and are more likely to cause serious side effects.

  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking triazolam.

  • you should know that triazolam may make you drowsy during the daytime, may decrease your mental alertness, and may increase the risk that you could fall. Take extra care to be sure you do not fall, especially if you get out of bed in the middle of the night. Do not drive a car or operate machinery until you know how this medication affects you.

  • you should know that some people who took medications for sleep got out of bed and drove their cars, prepared and ate food, had sex, made phone calls, or were involved in other activities while partially asleep. After they woke up, these people were usually unable to remember what they had done. Call your doctor right away if you find out that you have been driving or doing anything else while you were sleeping.

  • you should know that your mental health may change in unexpected ways while you are taking this medication. It is hard to tell if these changes are caused by triazolam or if they are caused by physical or mental illnesses that you already have or suddenly develop. Tell your doctor right away if you experience any of the following symptoms: aggressiveness, strange or unusually outgoing behavior, hallucinations (seeing things or hearing voices that do not exist), feeling as if you are outside of your body, memory problems, difficulty concentrating, slowed speech or movements, new or worsening depression, thinking about killing yourself, confusion, and any other changes in your usual thoughts, mood, or behavior. Be sure that your family knows which symptoms may be serious so that they can call the doctor if you are unable to seek treatment on your own.

Do not eat grapefruit or drink grapefruit juice while taking this medication.

Triazolam should only be taken at bedtime. If you did not take triazolam at bedtime and you are unable to fall asleep, you may take triazolam if you will be able to remain in bed for 7 to 8 hours afterward. Do not take triazolam if you are not ready to go to sleep right away and stay asleep for at least 7 to 8 hours.

  • Triazolam may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • drowsiness

    • dizziness

    • lightheadedness

    • headache

    • problems with coordination

    • nervousness

    • tingling of the skin

    • nausea

    • vomiting

  • Some side effects can be serious. If you experience any of these symptoms or those listed in the SPECIAL PRECAUTIONS or IMPORTANT WARNING sections, call your doctor immediately or get emergency medical help:

    • rash

    • hives

    • itching

    • swelling of the eyes, face, lips, tongue, or throat

    • feeling that the throat is closing

    • difficulty breathing or swallowing

    • hoarseness

  • Triazolam may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom). Keep triazolam in a safe place so that no one else can take it accidentally or on purpose. Keep track of how many capsules are left so you will know if any are missing.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include the following:

  • extreme drowsiness

  • confusion

  • problems with coordination

  • slurred speech

  • slow or difficult breathing

  • seizures

  • coma (loss of consciousness for a period of time)

Keep all appointments with your doctor and the laboratory. Your doctor may order certain lab tests to check your body's response to triazolam.

Do not let anyone else take your medication. Triazolam is a controlled substance. Prescriptions may be refilled only a limited number of times; ask your pharmacist if you have any questions.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Montelukast Montelukast The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Montelukast is combined with Triazolam.
Leflunomide Leflunomide The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Leflunomide.
Delavirdine Delavirdine The metabolism of Triazolam can be decreased when combined with Delavirdine.
Nevirapine Nevirapine The metabolism of Triazolam can be decreased when combined with Nevirapine.
Atorvastatin Atorvastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Atorvastatin.
Dolasetron Dolasetron The risk or severity of adverse effects can be increased when Dolasetron is combined with Triazolam.
Alendronate Alendronate The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Alendronic acid is combined with Triazolam.
Aminophylline Aminophylline The therapeutic efficacy of Triazolam can be decreased when used in combination with Aminophylline.
Cilostazol Cilostazol Triazolam may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Clopidogrel Clopidogrel The metabolism of Triazolam can be decreased when combined with Clopidogrel.
Diphenoxylate Diphenoxylate The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Triazolam.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole The serum concentration of Triazolam can be increased when it is combined with Erythromycin.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) Conjugated estrogens may decrease the excretion rate of Triazolam which could result in a higher serum level.
Fenofibrate Fenofibrate The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Fenofibrate.
Guanfacine Guanfacine The risk or severity of adverse effects can be increased when Triazolam is combined with Guanfacine.
Magnesium Hydroxide Magnesium Hydroxide Triazolam may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.
Mycophenolate Mycophenolate Triazolam may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.
Nafarelin Nafarelin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nafarelin is combined with Triazolam.
Naratriptan Naratriptan The risk or severity of adverse effects can be increased when Triazolam is combined with Naratriptan.
Olsalazine Olsalazine Olsalazine may decrease the excretion rate of Triazolam which could result in a higher serum level.
Paregoric Paregoric The risk or severity of adverse effects can be increased when Morphine is combined with Triazolam.
Pentazocine Pentazocine The risk or severity of adverse effects can be increased when Pentazocine is combined with Triazolam.
Potassium Potassium Potassium may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.
Prednisone Prednisone Prednisone may decrease the excretion rate of Triazolam which could result in a higher serum level.
Ranitidine Ranitidine The serum concentration of Triazolam can be increased when it is combined with Ranitidine.
Reserpine Reserpine The risk or severity of adverse effects can be increased when Reserpine is combined with Triazolam.
Rizatriptan Rizatriptan The risk or severity of adverse effects can be increased when Triazolam is combined with Rizatriptan.
Sumatriptan Sumatriptan The risk or severity of adverse effects can be increased when Sumatriptan is combined with Triazolam.
Tacrolimus Tacrolimus The metabolism of Triazolam can be decreased when combined with Tacrolimus.
Tizanidine Tizanidine The risk or severity of adverse effects can be increased when Tizanidine is combined with Triazolam.
Triamcinolone Triamcinolone The metabolism of Triazolam can be increased when combined with Triamcinolone.
Zolmitriptan Zolmitriptan The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Triazolam.
Ampicillin Injection Ampicillin Injection Ampicillin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Doxycycline Injection Doxycycline Injection Doxycycline may decrease the excretion rate of Triazolam which could result in a higher serum level.
Fluconazole Injection Fluconazole Injection The metabolism of Triazolam can be decreased when combined with Fluconazole.
Foscarnet Injection Foscarnet Injection Foscarnet may decrease the excretion rate of Triazolam which could result in a higher serum level.
Hydromorphone Injection Hydromorphone Injection The risk or severity of adverse effects can be increased when Hydromorphone is combined with Triazolam.
Levofloxacin Injection Levofloxacin Injection Triazolam may decrease the excretion rate of Levofloxacin which could result in a higher serum level.
Meperidine Injection Meperidine Injection The risk or severity of adverse effects can be increased when Meperidine is combined with Triazolam.
Metoclopramide Injection Metoclopramide Injection The risk or severity of sedation can be increased when Triazolam is combined with Metoclopramide.
Metronidazole Injection Metronidazole Injection The metabolism of Metronidazole can be decreased when combined with Triazolam.
Morphine Injection Morphine Injection The risk or severity of adverse effects can be increased when Morphine is combined with Triazolam.
Pamidronate Injection Pamidronate Injection Pamidronic acid may decrease the excretion rate of Triazolam which could result in a higher serum level.
Vancomycin Injection Vancomycin Injection Triazolam may decrease the excretion rate of Vancomycin which could result in a higher serum level.
Zidovudine Injection Zidovudine Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Triazolam.
Altretamine Altretamine The risk or severity of adverse effects can be increased when Amphetamine is combined with Triazolam.
Cefuroxime Cefuroxime Cefuroxime may decrease the excretion rate of Triazolam which could result in a higher serum level.
Cyclosporine Cyclosporine The metabolism of Triazolam can be decreased when combined with Cyclosporine.
Ondansetron Ondansetron The risk or severity of adverse effects can be increased when Triazolam is combined with Ondansetron.
Granisetron Granisetron The risk or severity of adverse effects can be increased when Granisetron is combined with Triazolam.
Torsemide Torsemide Torasemide may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.
Olanzapine Olanzapine The risk or severity of adverse effects can be increased when Olanzapine is combined with Triazolam.
Alosetron Alosetron The risk or severity of adverse effects can be increased when Triazolam is combined with Alosetron.
Entacapone Entacapone The risk or severity of adverse effects can be increased when Entacapone is combined with Triazolam.
Eprosartan Eprosartan The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Eprosartan is combined with Triazolam.
Meloxicam Meloxicam Meloxicam may decrease the excretion rate of Triazolam which could result in a higher serum level.
Oxcarbazepine Oxcarbazepine The risk or severity of adverse effects can be increased when Oxcarbazepine is combined with Triazolam.
Pantoprazole Pantoprazole Pantoprazole may decrease the excretion rate of Triazolam which could result in a higher serum level.
Risedronate Risedronate The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Risedronic acid is combined with Triazolam.
Temozolomide Temozolomide Temozolomide may decrease the excretion rate of Triazolam which could result in a higher serum level.
Zaleplon Zaleplon The risk or severity of adverse effects can be increased when Triazolam is combined with Zaleplon.
Anakinra Anakinra The metabolism of Triazolam can be increased when combined with Anakinra.
Desloratadine Desloratadine The risk or severity of adverse effects can be increased when Triazolam is combined with Desloratadine.
Linezolid Linezolid The risk or severity of adverse effects can be increased when Linezolid is combined with Triazolam.
Trimipramine Trimipramine The risk or severity of adverse effects can be increased when Trimipramine is combined with Triazolam.
Etanercept Injection Etanercept Injection The metabolism of Triazolam can be increased when combined with Etanercept.
Glycopyrrolate Glycopyrrolate Triazolam may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.
Modafinil Modafinil The metabolism of Triazolam can be increased when combined with Modafinil.
Perindopril Perindopril Perindopril may decrease the excretion rate of Triazolam which could result in a higher serum level.
Tenofovir Tenofovir Tenofovir may decrease the excretion rate of Triazolam which could result in a higher serum level.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate Choline magnesium trisalicylate may decrease the excretion rate of Triazolam which could result in a higher serum level.
Sirolimus Sirolimus The serum concentration of Triazolam can be increased when it is combined with Sirolimus.
Dutasteride Dutasteride The metabolism of Dutasteride can be decreased when combined with Triazolam.
Eplerenone Eplerenone Eplerenone may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.
Escitalopram Escitalopram The risk or severity of adverse effects can be increased when Triazolam is combined with Escitalopram.
Zonisamide Zonisamide Triazolam may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.
Adalimumab Injection Adalimumab Injection The metabolism of Triazolam can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole The risk or severity of adverse effects can be increased when Triazolam is combined with Aripiprazole.
Atomoxetine Atomoxetine The risk or severity of adverse effects can be increased when Atomoxetine is combined with Triazolam.
Dexmethylphenidate Dexmethylphenidate The risk or severity of adverse effects can be increased when Triazolam is combined with Dexmethylphenidate.
Atazanavir Atazanavir Atazanavir may decrease the excretion rate of Triazolam which could result in a higher serum level.
Almotriptan Almotriptan The risk or severity of adverse effects can be increased when Triazolam is combined with Almotriptan.
Eletriptan Eletriptan The risk or severity of adverse effects can be increased when Eletriptan is combined with Triazolam.
Mefloquine Mefloquine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Mefloquine is combined with Triazolam.
Rosuvastatin Rosuvastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Rosuvastatin.
Vardenafil Vardenafil The metabolism of Triazolam can be decreased when combined with Vardenafil.
Aprepitant Aprepitant The metabolism of Triazolam can be decreased when combined with Aprepitant.
Emtricitabine Emtricitabine Emtricitabine may decrease the excretion rate of Triazolam which could result in a higher serum level.
Memantine Memantine Triazolam may decrease the excretion rate of Memantine which could result in a higher serum level.
Tadalafil Tadalafil Tadalafil may decrease the excretion rate of Triazolam which could result in a higher serum level.
Frovatriptan Frovatriptan The risk or severity of adverse effects can be increased when Triazolam is combined with Frovatriptan.
Progesterone Progesterone The metabolism of Triazolam can be decreased when combined with Progesterone.
Apomorphine Injection Apomorphine Injection The risk or severity of adverse effects can be increased when Apomorphine is combined with Triazolam.
Infliximab Injection Infliximab Injection The metabolism of Triazolam can be increased when combined with Infliximab.
Protriptyline Protriptyline The risk or severity of adverse effects can be increased when Protriptyline is combined with Triazolam.
Duloxetine Duloxetine The risk or severity of adverse effects can be increased when Triazolam is combined with Duloxetine.
Norethindrone Norethindrone The metabolism of Triazolam can be decreased when combined with Norethisterone.
Tinidazole Tinidazole Triazolam may decrease the excretion rate of Tinidazole which could result in a higher serum level.
Trospium Trospium Triazolam may increase the central nervous system depressant (CNS depressant) activities of Trospium.
Cefditoren Cefditoren Cefdinir may decrease the excretion rate of Triazolam which could result in a higher serum level.
Cyanocobalamin Injection Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Erlotinib Erlotinib The metabolism of Triazolam can be decreased when combined with Erlotinib.
Eszopiclone Eszopiclone The risk or severity of CNS depression can be increased when Triazolam is combined with Eszopiclone.
Ganciclovir Ganciclovir The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Ganciclovir.
Ribavirin Ribavirin Ribavirin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Solifenacin Solifenacin Triazolam may increase the central nervous system depressant (CNS depressant) activities of Solifenacin.
Valganciclovir Valganciclovir Triazolam may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
Voriconazole Voriconazole The metabolism of Triazolam can be decreased when combined with Voriconazole.
Adefovir Adefovir Adefovir may decrease the excretion rate of Triazolam which could result in a higher serum level.
Dextroamphetamine Dextroamphetamine The risk or severity of adverse effects can be increased when Amphetamine is combined with Triazolam.
Sodium Oxybate Sodium Oxybate Triazolam may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.
Ibandronate Ibandronate The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ibandronate is combined with Triazolam.
Isocarboxazid Isocarboxazid The risk or severity of adverse effects can be increased when Triazolam is combined with Isocarboxazid.
Ramelteon Ramelteon The risk or severity of adverse effects can be increased when Triazolam is combined with Ramelteon.
Darifenacin Darifenacin Triazolam may increase the central nervous system depressant (CNS depressant) activities of Darifenacin.
Fentanyl Fentanyl The risk or severity of adverse effects can be increased when Fentanyl is combined with Triazolam.
Pregabalin Pregabalin The therapeutic efficacy of Triazolam can be increased when used in combination with Pregabalin.
Phenylephrine Phenylephrine The risk or severity of hypertension can be decreased when Triazolam is combined with Phenylephrine.
Felbamate Felbamate The risk or severity of adverse effects can be increased when Triazolam is combined with Felbamate.
Ranolazine Ranolazine Ranolazine may decrease the excretion rate of Triazolam which could result in a higher serum level.
Abatacept Injection Abatacept Injection The metabolism of Triazolam can be increased when combined with Abatacept.
Rasagiline Rasagiline The risk or severity of adverse effects can be increased when Triazolam is combined with Rasagiline.
Imatinib Imatinib The metabolism of Triazolam can be decreased when combined with Imatinib.
Sitagliptin Sitagliptin Triazolam may decrease the excretion rate of Sitagliptin which could result in a higher serum level.
Varenicline Varenicline Triazolam may decrease the excretion rate of Varenicline which could result in a higher serum level.
Gefitinib Gefitinib The metabolism of Triazolam can be decreased when combined with Gefitinib.
Albuterol Albuterol Triazolam may decrease the excretion rate of Salbutamol which could result in a higher serum level.
Paliperidone Paliperidone The risk or severity of adverse effects can be increased when Triazolam is combined with Paliperidone.
Clofarabine Injection Clofarabine Injection Clofarabine may decrease the excretion rate of Triazolam which could result in a higher serum level.
Lubiprostone Lubiprostone Triazolam may decrease the excretion rate of Lubiprostone which could result in a higher serum level.
Pemetrexed Injection Pemetrexed Injection Triazolam may decrease the excretion rate of Pemetrexed which could result in a higher serum level.
Dimenhydrinate Dimenhydrinate The risk or severity of adverse effects can be increased when Triazolam is combined with Dimenhydrinate.
Nabilone Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Triazolam.
Sorafenib Sorafenib The metabolism of Triazolam can be decreased when combined with Sorafenib.
Sunitinib Sunitinib The metabolism of Sunitinib can be decreased when combined with Triazolam.
Dronabinol Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Triazolam.
Lapatinib Lapatinib The metabolism of Lapatinib can be decreased when combined with Triazolam.
Levocetirizine Levocetirizine The risk or severity of adverse effects can be increased when Triazolam is combined with Levocetirizine.
Pegaptanib Injection Pegaptanib Injection Triazolam may decrease the excretion rate of Pegaptanib which could result in a higher serum level.
Dasatinib Dasatinib The metabolism of Dasatinib can be decreased when combined with Triazolam.
Armodafinil Armodafinil The metabolism of Triazolam can be increased when combined with Armodafinil.
Azacitidine Injection Azacitidine Injection Triazolam may decrease the excretion rate of Azacitidine which could result in a higher serum level.
Ivermectin Ivermectin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Triazolam.
Temsirolimus Temsirolimus The serum concentration of Triazolam can be increased when it is combined with Temsirolimus.
Lenalidomide Lenalidomide Lenalidomide may decrease the excretion rate of Triazolam which could result in a higher serum level.
Raltegravir Raltegravir The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Raltegravir.
Budesonide Budesonide The metabolism of Triazolam can be increased when combined with Budesonide.
Chloramphenicol Injection Chloramphenicol Injection The metabolism of Triazolam can be decreased when combined with Chloramphenicol.
Desmopressin Desmopressin Desmopressin may decrease the excretion rate of Triazolam which could result in a higher serum level.
OnabotulinumtoxinA Injection OnabotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Triazolam.
RimabotulinumtoxinB Injection RimabotulinumtoxinB Injection The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Triazolam.
Doripenem Injection Doripenem Injection Triazolam may decrease the excretion rate of Doripenem which could result in a higher serum level.
Arsenic Trioxide Injection Arsenic Trioxide Injection Triazolam may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.
Desvenlafaxine Desvenlafaxine The risk or severity of adverse effects can be increased when Triazolam is combined with Desvenlafaxine.
Cevimeline Cevimeline Cevimeline may decrease the excretion rate of Triazolam which could result in a higher serum level.
Tretinoin Tretinoin The metabolism of Triazolam can be decreased when combined with Tretinoin.
Certolizumab Injection Certolizumab Injection The metabolism of Triazolam can be increased when combined with Certolizumab pegol.
Ixabepilone Injection Ixabepilone Injection The serum concentration of Triazolam can be increased when it is combined with Ixabepilone.
Irinotecan Injection Irinotecan Injection The metabolism of Triazolam can be decreased when combined with Irinotecan.
Daptomycin Injection Daptomycin Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Daptomycin is combined with Triazolam.
Praziquantel Praziquantel The metabolism of Praziquantel can be decreased when combined with Triazolam.
Methylnaltrexone Injection Methylnaltrexone Injection Triazolam may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
Rufinamide Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Triazolam.
Midazolam Midazolam The risk or severity of adverse effects can be increased when Midazolam is combined with Triazolam.
Naltrexone Injection Naltrexone Injection The risk or severity of adverse effects can be increased when Naltrexone is combined with Triazolam.
Dexrazoxane Injection Dexrazoxane Injection Dexrazoxane may decrease the excretion rate of Triazolam which could result in a higher serum level.
Milnacipran Milnacipran The risk or severity of adverse effects can be increased when Triazolam is combined with Milnacipran.
Plerixafor Injection Plerixafor Injection Triazolam may decrease the excretion rate of Plerixafor which could result in a higher serum level.
Fesoterodine Fesoterodine Triazolam may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine.
Iloperidone Iloperidone The risk or severity of adverse effects can be increased when Triazolam is combined with Iloperidone.
Prasugrel Prasugrel Triazolam may decrease the excretion rate of Prasugrel which could result in a higher serum level.
Lacosamide Lacosamide The risk or severity of adverse effects can be increased when Triazolam is combined with Lacosamide.
Everolimus Everolimus The serum concentration of Triazolam can be increased when it is combined with Everolimus.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) Tolvaptan may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.
Dronedarone Dronedarone The metabolism of Triazolam can be decreased when combined with Dronedarone.
AbobotulinumtoxinA Injection AbobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Triazolam.
Pralatrexate Injection Pralatrexate Injection Triazolam may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
Palonosetron Injection Palonosetron Injection The risk or severity of adverse effects can be increased when Palonosetron is combined with Triazolam.
Saxagliptin Saxagliptin Triazolam may decrease the excretion rate of Saxagliptin which could result in a higher serum level.
Telavancin Injection Telavancin Injection Triazolam may decrease the excretion rate of Telavancin which could result in a higher serum level.
Romidepsin Injection Romidepsin Injection The metabolism of Romidepsin can be decreased when combined with Triazolam.
Tapentadol Tapentadol Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Triazolam.
Topotecan Topotecan Triazolam may decrease the excretion rate of Topotecan which could result in a higher serum level.
Golimumab Injection Golimumab Injection The metabolism of Triazolam can be increased when combined with Golimumab.
Asenapine Asenapine The risk or severity of adverse effects can be increased when Triazolam is combined with Asenapine.
Vigabatrin Vigabatrin The risk or severity of adverse effects can be increased when Triazolam is combined with Vigabatrin.
Pitavastatin Pitavastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Pitavastatin.
Levonorgestrel Levonorgestrel The metabolism of Triazolam can be decreased when combined with Levonorgestrel.
Oxymorphone Oxymorphone The risk or severity of adverse effects can be increased when Oxymorphone is combined with Triazolam.
Tocilizumab Injection Tocilizumab Injection The metabolism of Triazolam can be increased when combined with Tocilizumab.
Dalfampridine Dalfampridine Triazolam may decrease the excretion rate of Dalfampridine which could result in a higher serum level.
IncobotulinumtoxinA Injection IncobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Triazolam.
Cabazitaxel Injection Cabazitaxel Injection The metabolism of Cabazitaxel can be decreased when combined with Triazolam.
Ceftaroline Injection Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Triazolam which could result in a higher serum level.
Lurasidone Lurasidone The risk or severity of adverse effects can be increased when Triazolam is combined with Lurasidone.
Acetaminophen Injection Acetaminophen Injection Acetaminophen may decrease the excretion rate of Triazolam which could result in a higher serum level.
Vilazodone Vilazodone The risk or severity of adverse effects can be increased when Triazolam is combined with Vilazodone.
Ipilimumab Injection Ipilimumab Injection Triazolam may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Denileukin Diftitox Injection Denileukin Diftitox Injection Aldesleukin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Terbutaline Injection Terbutaline Injection Terbutaline may decrease the excretion rate of Triazolam which could result in a higher serum level.
Roflumilast Roflumilast Triazolam may decrease the excretion rate of Roflumilast which could result in a higher serum level.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Triazolam can be decreased when combined with Cyclophosphamide.
Rivaroxaban Rivaroxaban Triazolam may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.
Ruxolitinib Ruxolitinib Triazolam may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.
Clobazam Clobazam The risk or severity of adverse effects can be increased when Clobazam is combined with Triazolam.
Ivacaftor Ivacaftor The metabolism of Ivacaftor can be decreased when combined with Triazolam.
Deferiprone Deferiprone Triazolam may decrease the excretion rate of Deferiprone which could result in a higher serum level.
Axitinib Axitinib The metabolism of Axitinib can be decreased when combined with Triazolam.
Crizotinib Crizotinib The metabolism of Triazolam can be decreased when combined with Crizotinib.
Cabergoline Cabergoline The risk or severity of adverse effects can be increased when Cabergoline is combined with Triazolam.
Naloxone Injection Naloxone Injection Triazolam may decrease the excretion rate of Naloxone which could result in a higher serum level.
Ambrisentan Ambrisentan The metabolism of Ambrisentan can be decreased when combined with Triazolam.
Fondaparinux Injection Fondaparinux Injection Fondaparinux may decrease the excretion rate of Triazolam which could result in a higher serum level.
Ezogabine Ezogabine The risk or severity of adverse effects can be increased when Triazolam is combined with Tiagabine.
Iloprost Iloprost The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Iloprost.
Enzalutamide Enzalutamide The metabolism of Enzalutamide can be decreased when combined with Triazolam.
Mirabegron Mirabegron Triazolam may decrease the excretion rate of Mirabegron which could result in a higher serum level.
Teduglutide Injection Teduglutide Injection The serum concentration of Triazolam can be increased when it is combined with Teduglutide.
Alogliptin Alogliptin Triazolam may decrease the excretion rate of Alogliptin which could result in a higher serum level.
Ponatinib Ponatinib The metabolism of Ponatinib can be decreased when combined with Triazolam.
Pomalidomide Pomalidomide The risk or severity of adverse effects can be increased when Triazolam is combined with Pomalidomide.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The metabolism of Trastuzumab emtansine can be decreased when combined with Triazolam.
Apixaban Apixaban The metabolism of Apixaban can be decreased when combined with Triazolam.
Canagliflozin Canagliflozin Canagliflozin may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.
Methazolamide Methazolamide Methazolamide may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.
Trametinib Trametinib Triazolam may decrease the excretion rate of Trametinib which could result in a higher serum level.
Levomilnacipran Levomilnacipran The risk or severity of adverse effects can be increased when Triazolam is combined with Levomilnacipran.
Ertapenem Injection Ertapenem Injection Ertapenem may decrease the excretion rate of Triazolam which could result in a higher serum level.
Vortioxetine Vortioxetine The risk or severity of adverse effects can be increased when Triazolam is combined with Vortioxetine.
Perampanel Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Triazolam.
Ibrutinib Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Triazolam.
Ketorolac Injection Ketorolac Injection Ketorolac may decrease the excretion rate of Triazolam which could result in a higher serum level.
Simeprevir Simeprevir The serum concentration of Triazolam can be increased when it is combined with Simeprevir.
Sofosbuvir Sofosbuvir Triazolam may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
Dapagliflozin Dapagliflozin Dapagliflozin may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.
Apremilast Apremilast The metabolism of Triazolam can be increased when combined with Apremilast.
Droxidopa Droxidopa Triazolam may decrease the excretion rate of Droxidopa which could result in a higher serum level.
Siltuximab Injection Siltuximab Injection The metabolism of Triazolam can be increased when combined with Siltuximab.
Eslicarbazepine Eslicarbazepine The risk or severity of adverse effects can be increased when Triazolam is combined with Eslicarbazepine.
Testosterone Injection Testosterone Injection The metabolism of Triazolam can be decreased when combined with Testosterone.
Hydrocodone Hydrocodone Hydrocodone may increase the central nervous system depressant (CNS depressant) activities of Triazolam.
Suvorexant Suvorexant Triazolam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Edoxaban Edoxaban Triazolam may decrease the excretion rate of Edoxaban which could result in a higher serum level.
Olaparib Olaparib The metabolism of Olaparib can be decreased when combined with Triazolam.
Methamphetamine Methamphetamine The risk or severity of adverse effects can be increased when Triazolam is combined with Metamfetamine.
Tasimelteon Tasimelteon The risk or severity of adverse effects can be increased when Triazolam is combined with Tasimelteon.
Secukinumab Injection Secukinumab Injection The metabolism of Triazolam can be increased when combined with Secukinumab.
Risperidone Injection Risperidone Injection The risk or severity of adverse effects can be increased when Risperidone is combined with Triazolam.
Haloperidol Injection Haloperidol Injection The risk or severity of CNS depression can be increased when Haloperidol is combined with Triazolam.
Amiloride Amiloride Amiloride may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.
Macitentan Macitentan Triazolam may decrease the excretion rate of Macitentan which could result in a higher serum level.
Flibanserin Flibanserin The risk or severity of adverse effects can be increased when Triazolam is combined with Flibanserin.
Daclatasvir Daclatasvir The metabolism of Daclatasvir can be decreased when combined with Triazolam.
Brexpiprazole Brexpiprazole The risk or severity of adverse effects can be increased when Triazolam is combined with Brexpiprazole.
Ziprasidone Injection Ziprasidone Injection The risk or severity of adverse effects can be increased when Ziprasidone is combined with Triazolam.
Cariprazine Cariprazine The risk or severity of adverse effects can be increased when Triazolam is combined with Cariprazine.
Penicillin G Procaine Injection Penicillin G Procaine Injection Triazolam may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
Eluxadoline Eluxadoline The risk or severity of adverse effects can be increased when Eluxadoline is combined with Triazolam.
Trabectedin Injection Trabectedin Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Trabectedin.
Ixazomib Ixazomib Triazolam may decrease the excretion rate of Ixazomib which could result in a higher serum level.
Lesinurad Lesinurad Triazolam may decrease the excretion rate of Lesinurad which could result in a higher serum level.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection Amphotericin B may decrease the excretion rate of Triazolam which could result in a higher serum level.
Dexamethasone Injection Dexamethasone Injection The metabolism of Triazolam can be increased when combined with Dexamethasone.
Brivaracetam Injection Brivaracetam Injection The risk or severity of adverse effects can be increased when Triazolam is combined with Brivaracetam.
Cobicistat Cobicistat The metabolism of Triazolam can be decreased when combined with Cobicistat.
Pimavanserin Pimavanserin The risk or severity of adverse effects can be increased when Triazolam is combined with Pimavanserin.
Diphenhydramine Injection Diphenhydramine Injection The risk or severity of adverse effects can be increased when Triazolam is combined with Diphenhydramine.
Furosemide Injection Furosemide Injection Furosemide may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.
Rucaparib Rucaparib The metabolism of Triazolam can be decreased when combined with Rucaparib.
Lixisenatide Injection Lixisenatide Injection Triazolam may decrease the excretion rate of Lixisenatide which could result in a higher serum level.
Doxepin (Insomnia) Doxepin (Insomnia) Triazolam may increase the central nervous system depressant (CNS depressant) activities of Doxepin.
Deutetrabenazine Deutetrabenazine The risk or severity of sedation and somnolence can be increased when Triazolam is combined with Deutetrabenazine.
Valbenazine Valbenazine Triazolam may decrease the excretion rate of Valbenazine which could result in a higher serum level.
Deflazacort Deflazacort The metabolism of Triazolam can be increased when combined with Deflazacort.
Safinamide Safinamide The metabolism of Triazolam can be decreased when combined with Safinamide.
Naldemedine Naldemedine Triazolam may decrease the excretion rate of Naldemedine which could result in a higher serum level.
Midostaurin Midostaurin The metabolism of Triazolam can be increased when combined with Midostaurin.
Benznidazole Benznidazole Triazolam may decrease the excretion rate of Benznidazole which could result in a higher serum level.
Copanlisib Injection Copanlisib Injection The metabolism of Copanlisib can be decreased when combined with Triazolam.
Delafloxacin Delafloxacin Triazolam may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Acalabrutinib Acalabrutinib The metabolism of Triazolam can be decreased when combined with Acalabrutinib.
Letermovir Letermovir The metabolism of Triazolam can be decreased when combined with Letermovir.
Tetrabenazine Tetrabenazine The risk or severity of sedation and somnolence can be increased when Triazolam is combined with Tetrabenazine.
Ertugliflozin Ertugliflozin Ertugliflozin may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.
Buprenorphine Injection Buprenorphine Injection Triazolam may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Apalutamide Apalutamide Triazolam may decrease the excretion rate of Apalutamide which could result in a higher serum level.
Penicillamine Penicillamine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Penicillamine is combined with Triazolam.
Baricitinib Baricitinib Triazolam may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Lofexidine Lofexidine The therapeutic efficacy of Triazolam can be increased when used in combination with Lofexidine.
Plazomicin Injection Plazomicin Injection Triazolam may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Doravirine Doravirine The metabolism of Doravirine can be decreased when combined with Triazolam.
Cannabidiol Cannabidiol The risk or severity of adverse effects can be increased when Cannabidiol is combined with Triazolam.
Stiripentol Stiripentol The risk or severity of adverse effects can be increased when Triazolam is combined with Stiripentol.
Lorlatinib Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Triazolam.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Triazolam.
Prucalopride Prucalopride Triazolam may decrease the excretion rate of Prucalopride which could result in a higher serum level.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Triazolam can be increased when combined with Emapalumab.
Acyclovir Ophthalmic Acyclovir Ophthalmic Acyclovir may decrease the excretion rate of Triazolam which could result in a higher serum level.
Brexanolone Injection Brexanolone Injection The risk or severity of adverse effects can be increased when Triazolam is combined with Brexanolone.
Cladribine Cladribine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cladribine is combined with Triazolam.
Solriamfetol Solriamfetol The risk or severity of adverse effects can be increased when Triazolam is combined with Solriamfetol.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Triazolam.
Pitolisant Pitolisant The serum concentration of Triazolam can be decreased when it is combined with Pitolisant.
Phenytoin Injection Phenytoin Injection The risk or severity of adverse effects can be increased when Phenytoin is combined with Triazolam.
Fosphenytoin Injection Fosphenytoin Injection The risk or severity of adverse effects can be increased when Triazolam is combined with Fosphenytoin.
Lumateperone Lumateperone The risk or severity of adverse effects can be increased when Triazolam is combined with Lumateperone.
Lasmiditan Lasmiditan The risk or severity of adverse effects can be increased when Triazolam is combined with Lasmiditan.
Cenobamate Cenobamate The serum concentration of Triazolam can be decreased when it is combined with Cenobamate.
Selumetinib Selumetinib The metabolism of Selumetinib can be decreased when combined with Triazolam.
Tucatinib Tucatinib The metabolism of Tucatinib can be decreased when combined with Triazolam.
Lemborexant Lemborexant The risk or severity of adverse effects can be increased when Triazolam is combined with Lemborexant.
Fenfluramine Fenfluramine The risk or severity of adverse effects can be increased when Fenfluramine is combined with Triazolam.
Pralsetinib Pralsetinib The metabolism of Triazolam can be decreased when combined with Pralsetinib.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Triazolam can be decreased when it is combined with Satralizumab.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives Drospirenone may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.
Viloxazine Viloxazine The risk or severity of adverse effects can be increased when Triazolam is combined with Viloxazine.
Tobramycin Injection Tobramycin Injection Tobramycin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Theophylline Theophylline The therapeutic efficacy of Triazolam can be decreased when used in combination with Theophylline.
Fenoprofen Fenoprofen Fenoprofen may decrease the excretion rate of Triazolam which could result in a higher serum level.
Indomethacin Indomethacin Indomethacin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Mefenamic Acid Mefenamic Acid Mefenamic acid may decrease the excretion rate of Triazolam which could result in a higher serum level.
Naproxen Naproxen Naproxen may decrease the excretion rate of Triazolam which could result in a higher serum level.
Tolmetin Tolmetin Tolmetin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Sulindac Sulindac Sulindac may decrease the excretion rate of Triazolam which could result in a higher serum level.
Trazodone Trazodone The risk or severity of adverse effects can be increased when Trazodone is combined with Triazolam.
Isotretinoin Isotretinoin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Isotretinoin.
Sucralfate Sucralfate Sucralfate may decrease the excretion rate of Triazolam which could result in a higher serum level.
Floxuridine Floxuridine Floxuridine may decrease the excretion rate of Triazolam which could result in a higher serum level.
Phenobarbital Phenobarbital The risk or severity of adverse effects can be increased when Triazolam is combined with Phenobarbital.
Metaxalone Metaxalone The risk or severity of adverse effects can be increased when Metaxalone is combined with Triazolam.
Methotrexate Injection Methotrexate Injection Methotrexate may decrease the excretion rate of Triazolam which could result in a higher serum level.
Levorphanol Levorphanol The risk or severity of adverse effects can be increased when Levorphanol is combined with Triazolam.
Primidone Primidone The risk or severity of adverse effects can be increased when Primidone is combined with Triazolam.
Methsuximide Methsuximide The risk or severity of adverse effects can be increased when Triazolam is combined with Methsuximide.
Diethylpropion Diethylpropion The risk or severity of adverse effects can be increased when Triazolam is combined with Diethylpropion.
Chlorpromazine Chlorpromazine Triazolam may increase the central nervous system depressant (CNS depressant) activities of Chlorpromazine.
Diazepam Diazepam The risk or severity of adverse effects can be increased when Diazepam is combined with Triazolam.
Oxazepam Oxazepam The risk or severity of adverse effects can be increased when Oxazepam is combined with Triazolam.
Flurazepam Flurazepam The risk or severity of adverse effects can be increased when Flurazepam is combined with Triazolam.
Clorazepate Clorazepate The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Triazolam.
Lorazepam Lorazepam The risk or severity of adverse effects can be increased when Lorazepam is combined with Triazolam.
Carmustine Carmustine Carmustine may decrease the excretion rate of Triazolam which could result in a higher serum level.
Amantadine Amantadine Triazolam may decrease the excretion rate of Amantadine which could result in a higher serum level.
Codeine Codeine The risk or severity of adverse effects can be increased when Codeine is combined with Triazolam.
Meprobamate Meprobamate The risk or severity of adverse effects can be increased when Meprobamate is combined with Triazolam.
Chlordiazepoxide Chlordiazepoxide The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Triazolam.
Bromocriptine Bromocriptine The risk or severity of adverse effects can be increased when Triazolam is combined with Bromocriptine.
Tranylcypromine Tranylcypromine The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Triazolam.
Phenelzine Phenelzine The risk or severity of adverse effects can be increased when Phenelzine is combined with Triazolam.
Procarbazine Procarbazine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Procarbazine.
Ergoloid Mesylates Ergoloid Mesylates The risk or severity of adverse effects can be increased when Triazolam is combined with Ergoloid mesylate.
Tetracycline Tetracycline Tetracycline may decrease the excretion rate of Triazolam which could result in a higher serum level.
Minocycline Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Triazolam.
Prochlorperazine Prochlorperazine The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Triazolam.
Thioridazine Thioridazine The risk or severity of adverse effects can be increased when Thioridazine is combined with Triazolam.
Trifluoperazine Trifluoperazine The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Triazolam.
Bleomycin Bleomycin Bleomycin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Dapsone Dapsone The metabolism of Triazolam can be decreased when combined with Dapsone.
Sulfadiazine Sulfadiazine Sulfadiazine may decrease the excretion rate of Triazolam which could result in a higher serum level.
Oxycodone Oxycodone The risk or severity of adverse effects can be increased when Oxycodone is combined with Triazolam.
Methadone Methadone Triazolam may increase the central nervous system depressant (CNS depressant) activities of Methadone.
Oxybutynin Oxybutynin Triazolam may increase the central nervous system depressant (CNS depressant) activities of Oxybutynin.
Benztropine Benztropine Triazolam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
Maprotiline Maprotiline The risk or severity of adverse effects can be increased when Triazolam is combined with Maprotiline.
Ibuprofen Ibuprofen Ibuprofen may decrease the excretion rate of Triazolam which could result in a higher serum level.
Trihexyphenidyl Trihexyphenidyl Triazolam may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.
Orphenadrine Orphenadrine Triazolam may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Perphenazine Perphenazine The risk or severity of adverse effects can be increased when Perphenazine is combined with Triazolam.
Azathioprine Azathioprine Triazolam may decrease the excretion rate of Azathioprine which could result in a higher serum level.
Fluphenazine Fluphenazine The risk or severity of adverse effects can be increased when Fluphenazine is combined with Triazolam.
Methylphenidate Methylphenidate Methylphenidate may decrease the excretion rate of Triazolam which could result in a higher serum level.
Amoxapine Amoxapine The risk or severity of adverse effects can be increased when Amoxapine is combined with Triazolam.
Sulfasalazine Sulfasalazine Sulfasalazine may decrease the excretion rate of Triazolam which could result in a higher serum level.
Hydrocortisone Hydrocortisone The metabolism of Triazolam can be decreased when combined with Hydrocortisone.
Cytarabine Cytarabine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Cytarabine.
Phenazopyridine Phenazopyridine Phenazopyridine may decrease the excretion rate of Triazolam which could result in a higher serum level.
Carbamazepine Carbamazepine The metabolism of Triazolam can be decreased when combined with Carbamazepine.
Molindone Molindone The risk or severity of adverse effects can be increased when Triazolam is combined with Molindone.
Methyldopa Methyldopa The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Methyldopa.
Clonidine Clonidine The risk or severity of sedation can be increased when Clonidine is combined with Triazolam.
Hydralazine Hydralazine Triazolam may decrease the excretion rate of Hydralazine which could result in a higher serum level.
Cimetidine Cimetidine The metabolism of Triazolam can be decreased when combined with Cimetidine.
Gentamicin Injection Gentamicin Injection Gentamicin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Warfarin Warfarin Warfarin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Clonazepam Clonazepam The risk or severity of adverse effects can be increased when Triazolam is combined with Clonazepam.
Promethazine Promethazine The risk or severity of adverse effects can be increased when Triazolam is combined with Promethazine.
Meclofenamate Meclofenamate Meclofenamic acid may decrease the excretion rate of Triazolam which could result in a higher serum level.
Daunorubicin Daunorubicin The metabolism of Triazolam can be increased when combined with Daunorubicin.
Nitrofurantoin Nitrofurantoin Nitrofurantoin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Digoxin Digoxin Triazolam may decrease the excretion rate of Digoxin which could result in a higher serum level.
Loxapine Loxapine The risk or severity of adverse effects can be increased when Loxapine is combined with Triazolam.
Chloroquine Chloroquine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Triazolam.
Quinine Quinine The risk or severity of adverse effects can be increased when Quinine is combined with Triazolam.
Ethosuximide Ethosuximide The risk or severity of adverse effects can be increased when Ethosuximide is combined with Triazolam.
Triamterene Triamterene Triamterene may decrease the excretion rate of Triazolam which could result in a higher serum level.
Chlorothiazide Chlorothiazide Chlorothiazide may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.
Chlorthalidone Chlorthalidone Chlorthalidone may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.
Metolazone Metolazone Metolazone may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.
Isosorbide Isosorbide Isosorbide may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.
Clindamycin Injection Clindamycin Injection The serum concentration of Clindamycin can be increased when it is combined with Triazolam.
Secobarbital Secobarbital The risk or severity of adverse effects can be increased when Secobarbital is combined with Triazolam.
Desipramine Desipramine Triazolam may increase the central nervous system depressant (CNS depressant) activities of Desipramine.
Amitriptyline Amitriptyline Triazolam may increase the central nervous system depressant (CNS depressant) activities of Amitriptyline.
Imipramine Imipramine Triazolam may increase the central nervous system depressant (CNS depressant) activities of Imipramine.
Probenecid Probenecid Triazolam may decrease the excretion rate of Probenecid which could result in a higher serum level.
Quinidine Quinidine The metabolism of Triazolam can be decreased when combined with Quinidine.
Procainamide Procainamide Triazolam may decrease the excretion rate of Procainamide which could result in a higher serum level.
Isoniazid Isoniazid The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Isoniazid.
Pyrazinamide Pyrazinamide Pyrazinamide may decrease the excretion rate of Triazolam which could result in a higher serum level.
Rifampin Rifampin The metabolism of Triazolam can be increased when combined with Rifampicin.
Disopyramide Disopyramide Triazolam may increase the central nervous system depressant (CNS depressant) activities of Disopyramide.
Valproic Acid Valproic Acid The risk or severity of adverse effects can be increased when Valproic acid is combined with Triazolam.
Tamoxifen Tamoxifen The metabolism of Triazolam can be decreased when combined with Tamoxifen.
Butabarbital Butabarbital The risk or severity of adverse effects can be increased when Butabarbital is combined with Triazolam.
Liothyronine Liothyronine Liothyronine may decrease the excretion rate of Triazolam which could result in a higher serum level.
Methimazole Methimazole Methimazole may decrease the excretion rate of Triazolam which could result in a higher serum level.
Propylthiouracil Propylthiouracil The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Propylthiouracil is combined with Triazolam.
Chlorpropamide Chlorpropamide Chlorpropamide may decrease the excretion rate of Triazolam which could result in a higher serum level.
Tolbutamide Tolbutamide Triazolam may decrease the excretion rate of Tolbutamide which could result in a higher serum level.
Tolazamide Tolazamide Tolazamide may decrease the excretion rate of Triazolam which could result in a higher serum level.
Dextromethorphan Dextromethorphan The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Triazolam.
Cyclobenzaprine Cyclobenzaprine The risk or severity of CNS depression can be increased when Triazolam is combined with Cyclobenzaprine.
Niacin Niacin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Triazolam.
Baclofen Baclofen The risk or severity of adverse effects can be increased when Baclofen is combined with Triazolam.
Doxylamine Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Triazolam.
Cyproheptadine Cyproheptadine Triazolam may increase the central nervous system depressant (CNS depressant) activities of Cyproheptadine.
Clemastine Clemastine The risk or severity of adverse effects can be increased when Clemastine is combined with Triazolam.
Chlorpheniramine Chlorpheniramine The risk or severity of adverse effects can be increased when Triazolam is combined with Chlorpheniramine.
Brompheniramine Brompheniramine The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Triazolam.
Meclizine Meclizine The risk or severity of adverse effects can be increased when Meclizine is combined with Triazolam.
Ethambutol Ethambutol Ethambutol may decrease the excretion rate of Triazolam which could result in a higher serum level.
Methyclothiazide Methyclothiazide Methyclothiazide may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.
Hydrochlorothiazide Hydrochlorothiazide Hydrochlorothiazide may decrease the excretion rate of Triazolam which could result in a higher serum level.
Dantrolene Dantrolene The risk or severity of adverse effects can be increased when Triazolam is combined with Dantrolene.
Chlorzoxazone Chlorzoxazone The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Triazolam.
Carisoprodol Carisoprodol The risk or severity of adverse effects can be increased when Carisoprodol is combined with Triazolam.
Methocarbamol Methocarbamol The risk or severity of adverse effects can be increased when Methocarbamol is combined with Triazolam.
Pyridoxine Pyridoxine Pyridoxine may decrease the excretion rate of Triazolam which could result in a higher serum level.
Folic Acid Folic Acid Folic acid may decrease the excretion rate of Triazolam which could result in a higher serum level.
Disulfiram Disulfiram The metabolism of Triazolam can be decreased when combined with Disulfiram.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) Propranolol may decrease the excretion rate of Triazolam which could result in a higher serum level.
Nortriptyline Nortriptyline Triazolam may increase the central nervous system depressant (CNS depressant) activities of Nortriptyline.
Spironolactone Spironolactone Spironolactone may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.
Amphotericin B Injection Amphotericin B Injection Amphotericin B may decrease the excretion rate of Triazolam which could result in a higher serum level.
Mercaptopurine Mercaptopurine The therapeutic efficacy of Triazolam can be decreased when used in combination with Mercaptopurine.
Phytonadione Phytonadione Triazolam may decrease the excretion rate of Phylloquinone which could result in a higher serum level.
Amikacin Injection Amikacin Injection Amikacin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Nadolol Nadolol Triazolam may decrease the excretion rate of Nadolol which could result in a higher serum level.
Butorphanol Injection Butorphanol Injection The risk or severity of adverse effects can be increased when Butorphanol is combined with Triazolam.
Nalbuphine Injection Nalbuphine Injection The risk or severity of adverse effects can be increased when Nalbuphine is combined with Triazolam.
Allopurinol Allopurinol Allopurinol may decrease the excretion rate of Triazolam which could result in a higher serum level.
Trimethobenzamide Trimethobenzamide The risk or severity of adverse effects can be increased when Trimethobenzamide is combined with Triazolam.
Flavoxate Flavoxate Triazolam may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.
Colchicine Colchicine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Colchicine.
Cefaclor Cefaclor Cefaclor may decrease the excretion rate of Triazolam which could result in a higher serum level.
Cefadroxil Cefadroxil Cefadroxil may decrease the excretion rate of Triazolam which could result in a higher serum level.
Cefazolin Injection Cefazolin Injection Cefazolin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Cephalexin Cephalexin Cephalexin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Cefoxitin Injection Cefoxitin Injection Cefoxitin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Dacarbazine Dacarbazine Dacarbazine may decrease the excretion rate of Triazolam which could result in a higher serum level.
Acetazolamide Acetazolamide The risk or severity of adverse effects can be increased when Acetazolamide is combined with Triazolam.
Cefotaxime Injection Cefotaxime Injection Cefotaxime may decrease the excretion rate of Triazolam which could result in a higher serum level.
Calcitonin Salmon Injection Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Ketoconazole Ketoconazole The metabolism of Triazolam can be decreased when combined with Ketoconazole.
Pyrantel Pyrantel The risk or severity of adverse effects can be increased when Triazolam is combined with Pyrantel.
Vincristine Injection Vincristine Injection The metabolism of Triazolam can be decreased when combined with Vincristine.
Captopril Captopril The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Captopril.
Ethacrynic Acid Ethacrynic Acid Etacrynic acid may decrease the excretion rate of Triazolam which could result in a higher serum level.
Colistimethate Injection Colistimethate Injection Colistimethate may decrease the excretion rate of Triazolam which could result in a higher serum level.
Metoprolol Metoprolol Metoprolol may decrease the excretion rate of Triazolam which could result in a higher serum level.
Hydroxyzine Hydroxyzine Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Triazolam.
Thiothixene Thiothixene The risk or severity of adverse effects can be increased when Triazolam is combined with Thiothixene.
Aspirin Aspirin Acetylsalicylic acid may decrease the excretion rate of Triazolam which could result in a higher serum level.
Salsalate Salsalate Salsalate may decrease the excretion rate of Triazolam which could result in a higher serum level.
Alprazolam Alprazolam The risk or severity of adverse effects can be increased when Alprazolam is combined with Triazolam.
Temazepam Temazepam The risk or severity of adverse effects can be increased when Temazepam is combined with Triazolam.
Dicyclomine Dicyclomine Triazolam may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Hyoscyamine Hyoscyamine Triazolam may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine.
Propantheline Propantheline Triazolam may increase the central nervous system depressant (CNS depressant) activities of Propantheline.
Trimethoprim Trimethoprim The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Trimethoprim is combined with Triazolam.
Diltiazem Diltiazem The metabolism of Triazolam can be decreased when combined with Diltiazem.
Nifedipine Nifedipine The metabolism of Nifedipine can be decreased when combined with Triazolam.
Timolol Timolol Timolol may decrease the excretion rate of Triazolam which could result in a higher serum level.
Verapamil Verapamil The metabolism of Triazolam can be decreased when combined with Verapamil.
Pindolol Pindolol The risk or severity of adverse effects can be increased when Triazolam is combined with Pindolol.
Cisplatin Injection Cisplatin Injection Triazolam may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Diflunisal Diflunisal Diflunisal may decrease the excretion rate of Triazolam which could result in a higher serum level.
Piroxicam Piroxicam Piroxicam may decrease the excretion rate of Triazolam which could result in a higher serum level.
Bumetanide Bumetanide The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Bumetanide is combined with Triazolam.
Etoposide Etoposide The metabolism of Triazolam can be decreased when combined with Etoposide.
Glyburide Glyburide The metabolism of Glyburide can be decreased when combined with Triazolam.
Glipizide Glipizide Triazolam may decrease the excretion rate of Glipizide which could result in a higher serum level.
Indapamide Indapamide Indapamide may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.
Amoxicillin Amoxicillin Triazolam may decrease the excretion rate of Amoxicillin which could result in a higher serum level.
Oxacillin Injection Oxacillin Injection Oxacillin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Pentoxifylline Pentoxifylline The therapeutic efficacy of Triazolam can be decreased when used in combination with Pentoxifylline.
Pentamidine Injection Pentamidine Injection Pentamidine may decrease the excretion rate of Triazolam which could result in a higher serum level.
Ceftriaxone Injection Ceftriaxone Injection Ceftriaxone may decrease the excretion rate of Triazolam which could result in a higher serum level.
Labetalol Labetalol Labetalol may decrease the excretion rate of Triazolam which could result in a higher serum level.
Auranofin Auranofin Triazolam may decrease the excretion rate of Auranofin which could result in a higher serum level.
Leuprolide Injection Leuprolide Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Triazolam.
Gemfibrozil Gemfibrozil The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Gemfibrozil.
Dipivefrin Ophthalmic Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Triazolam which could result in a higher serum level.
Ceftazidime Injection Ceftazidime Injection Ceftazidime may decrease the excretion rate of Triazolam which could result in a higher serum level.
Ketoprofen Ketoprofen Ketoprofen may decrease the excretion rate of Triazolam which could result in a higher serum level.
Cefotetan Injection Cefotetan Injection Cefotetan may decrease the excretion rate of Triazolam which could result in a higher serum level.
Pimozide Pimozide The metabolism of Pimozide can be decreased when combined with Triazolam.
Enalapril Enalapril The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Enalapril is combined with Triazolam.
Flurbiprofen Flurbiprofen Flurbiprofen may decrease the excretion rate of Triazolam which could result in a higher serum level.
Amiodarone Amiodarone The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Amiodarone.
Aztreonam Injection Aztreonam Injection Aztreonam may decrease the excretion rate of Triazolam which could result in a higher serum level.
Buspirone Buspirone Buspirone may decrease the excretion rate of Triazolam which could result in a higher serum level.
Lovastatin Lovastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lovastatin is combined with Triazolam.
Ciprofloxacin Ciprofloxacin The metabolism of Triazolam can be decreased when combined with Ciprofloxacin.
Mesalamine Mesalamine Mesalazine may decrease the excretion rate of Triazolam which could result in a higher serum level.
Diclofenac Diclofenac Diclofenac may decrease the excretion rate of Triazolam which could result in a higher serum level.
Fluoxetine Fluoxetine The serum concentration of Triazolam can be increased when it is combined with Fluoxetine.
Clozapine Clozapine The risk or severity of adverse effects can be increased when Triazolam is combined with Clozapine.
Estazolam Estazolam The risk or severity of adverse effects can be increased when Triazolam is combined with Estazolam.
Ofloxacin Ofloxacin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Ofloxacin.
Didanosine Didanosine Triazolam may decrease the excretion rate of Didanosine which could result in a higher serum level.
Pentostatin Injection Pentostatin Injection Pentostatin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Clarithromycin Clarithromycin The serum concentration of Triazolam can be increased when it is combined with Clarithromycin.
Etodolac Etodolac Etodolac may decrease the excretion rate of Triazolam which could result in a higher serum level.
Felodipine Felodipine The metabolism of Felodipine can be decreased when combined with Triazolam.
Fosinopril Fosinopril Fosinopril may decrease the excretion rate of Triazolam which could result in a higher serum level.
Nabumetone Nabumetone Nabumetone may decrease the excretion rate of Triazolam which could result in a higher serum level.
Pravastatin Pravastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Triazolam.
Simvastatin Simvastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Simvastatin is combined with Triazolam.
Teniposide Injection Teniposide Injection The metabolism of Triazolam can be decreased when combined with Teniposide.
Itraconazole Itraconazole The metabolism of Triazolam can be decreased when combined with Itraconazole.
Lisinopril Lisinopril Lisinopril may decrease the excretion rate of Triazolam which could result in a higher serum level.
Oxaprozin Oxaprozin Oxaprozin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Bisoprolol Bisoprolol Bisoprolol may decrease the excretion rate of Triazolam which could result in a higher serum level.
Zolpidem Zolpidem Triazolam may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Isradipine Isradipine Isradipine may decrease the excretion rate of Triazolam which could result in a higher serum level.
Cisapride Cisapride The risk or severity of adverse effects can be increased when Cisapride is combined with Triazolam.
Gabapentin Gabapentin The risk or severity of adverse effects can be increased when Triazolam is combined with Gabapentin.
Fluvastatin Fluvastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Fluvastatin.
Venlafaxine Venlafaxine The risk or severity of adverse effects can be increased when Venlafaxine is combined with Triazolam.
Nizatidine Nizatidine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nizatidine is combined with Triazolam.
Stavudine Stavudine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Triazolam.
Fluvoxamine Fluvoxamine The risk or severity of adverse effects can be increased when Triazolam is combined with Fluvoxamine.
Nefazodone Nefazodone The risk or severity of adverse effects can be increased when Triazolam is combined with Nefazodone.
Lamotrigine Lamotrigine The risk or severity of adverse effects can be increased when Lamotrigine is combined with Triazolam.
Valacyclovir Valacyclovir Valaciclovir may decrease the excretion rate of Triazolam which could result in a higher serum level.
Tramadol Tramadol The risk or severity of CNS depression can be increased when Tramadol is combined with Triazolam.
Carboplatin Injection Carboplatin Injection Carboplatin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Ifosfamide Injection Ifosfamide Injection The metabolism of Ifosfamide can be decreased when combined with Triazolam.
Nicardipine Nicardipine Triazolam may increase the central nervous system depressant (CNS depressant) activities of Nicardipine.
Bupropion Bupropion The risk or severity of adverse effects can be increased when Triazolam is combined with Bupropion.
Ticlopidine Ticlopidine Ticlopidine may decrease the excretion rate of Triazolam which could result in a higher serum level.
Saquinavir Saquinavir The serum concentration of Triazolam can be increased when it is combined with Saquinavir.
Metformin Metformin Metformin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Nisoldipine Nisoldipine Nisoldipine may decrease the excretion rate of Triazolam which could result in a higher serum level.
Lamivudine Lamivudine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Triazolam.
Riluzole Riluzole The risk or severity of adverse effects can be increased when Riluzole is combined with Triazolam.
Acarbose Acarbose Acarbose may decrease the excretion rate of Triazolam which could result in a higher serum level.
Gemcitabine Injection Gemcitabine Injection Gemcitabine may decrease the excretion rate of Triazolam which could result in a higher serum level.
Indinavir Indinavir The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Triazolam.
Ritonavir Ritonavir The serum concentration of Triazolam can be increased when it is combined with Ritonavir.
Docetaxel Injection Docetaxel Injection The metabolism of Docetaxel can be decreased when combined with Triazolam.
Cidofovir Injection Cidofovir Injection Cidofovir may decrease the excretion rate of Triazolam which could result in a higher serum level.
Meropenem Injection Meropenem Injection Meropenem may decrease the excretion rate of Triazolam which could result in a higher serum level.
Clomipramine Clomipramine The risk or severity of adverse effects can be increased when Triazolam is combined with Clomipramine.
Fosfomycin Fosfomycin Fosfomycin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Mirtazapine Mirtazapine Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Triazolam.
Topiramate Topiramate The risk or severity of adverse effects can be increased when Topiramate is combined with Triazolam.
Pramipexole Pramipexole Triazolam may increase the sedative activities of Pramipexole.
Donepezil Donepezil The risk or severity of adverse effects can be increased when Donepezil is combined with Triazolam.
Nelfinavir Nelfinavir The metabolism of Triazolam can be decreased when combined with Nelfinavir.
Nilutamide Nilutamide Nilutamide may decrease the excretion rate of Triazolam which could result in a higher serum level.
Flutamide Flutamide Flutamide may decrease the excretion rate of Triazolam which could result in a higher serum level.
Selegiline Selegiline The risk or severity of adverse effects can be increased when Triazolam is combined with Selegiline.
Sertraline Sertraline The risk or severity of adverse effects can be increased when Triazolam is combined with Sertraline.
Letrozole Letrozole The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Letrozole.
Tamsulosin Tamsulosin Tamsulosin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Ropinirole Ropinirole Triazolam may increase the sedative activities of Ropinirole.
Finasteride Finasteride The metabolism of Finasteride can be decreased when combined with Triazolam.
Quetiapine Quetiapine The risk or severity of adverse effects can be increased when Triazolam is combined with Quetiapine.
Cefepime Injection Cefepime Injection Cefepime may decrease the excretion rate of Triazolam which could result in a higher serum level.
Cefprozil Cefprozil Cefprozil may decrease the excretion rate of Triazolam which could result in a higher serum level.
Cefpodoxime Cefpodoxime Cefpodoxime may decrease the excretion rate of Triazolam which could result in a higher serum level.
Cetirizine Cetirizine The risk or severity of adverse effects can be increased when Cetirizine is combined with Triazolam.
Paroxetine Paroxetine The risk or severity of adverse effects can be increased when Triazolam is combined with Paroxetine.
Tolcapone Tolcapone The risk or severity of adverse effects can be increased when Tolcapone is combined with Triazolam.
Citalopram Citalopram The risk or severity of adverse effects can be increased when Triazolam is combined with Citalopram.
Capecitabine Capecitabine Triazolam may decrease the excretion rate of Capecitabine which could result in a higher serum level.
Efavirenz Efavirenz The risk or severity of adverse effects can be increased when Efavirenz is combined with Triazolam.
Abacavir Abacavir Triazolam may decrease the excretion rate of Abacavir which could result in a higher serum level.
Sildenafil Sildenafil The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Sildenafil is combined with Triazolam.
Celecoxib Celecoxib Celecoxib may decrease the excretion rate of Triazolam which could result in a higher serum level.
Rosiglitazone Rosiglitazone Rosiglitazone may decrease the excretion rate of Triazolam which could result in a higher serum level.
Tolterodine Tolterodine Triazolam may increase the central nervous system depressant (CNS depressant) activities of Tolterodine.
Thalidomide Thalidomide Triazolam may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Oseltamivir Oseltamivir Oseltamivir may decrease the excretion rate of Triazolam which could result in a higher serum level.
Balsalazide Balsalazide Balsalazide may decrease the excretion rate of Triazolam which could result in a higher serum level.
Nateglinide Nateglinide Nateglinide may decrease the excretion rate of Triazolam which could result in a higher serum level.
Levetiracetam Levetiracetam The risk or severity of adverse effects can be increased when Levetiracetam is combined with Triazolam.
Rabeprazole Rabeprazole Triazolam may decrease the excretion rate of Rabeprazole which could result in a higher serum level.
Terbinafine Terbinafine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Terbinafine is combined with Triazolam.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists